RA Capital Management »

Progyny shares owned by RA Capital Management

Quarter-by-quarter ownership of Progyny (PGNY) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Progyny

Tip: Access up to 7 years of quarterly data

All positions including Progyny held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Progyny by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1M 97k 21.52

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Progyny

BlackRock
Vanguard Group
FMR
State Street Corporation
Thrivent Financial for Lutherans
Geode Capital Management
Arrowpoint Asset Management
Ameriprise Financial
Fred Alger Management
Fort Washington Investment Advisors
Barclays
Goldman Sachs Group
Dimensional Fund Advisors
Morgan Stanley
Baillie Gifford & Co

View all funds holding Progyny